We recognise the relationship between climate and health. Climate change will put the health ecosystem under pressure across all stakeholders – health providers, patient and payers – in low-, middle- and high-income settings. Therefore, we take actions to reduce our carbon emissions and adapt to the shifts in health systems across our value chain and in our product portfolio.

In the scientific debate, we refer to the findings of the UN Intergovernmental Panel on Climate Change (IPCC).  We acknowledge the overwhelming scientific evidence of the IPCC experts and agree with the need to limit global warming to 1.5 °C as set out in the Paris Agreement.

Since 2020, all our production sites have sourced renewable power, and we have a target of reaching zero CO₂ emissions from operations and transportation by 2030. 

We adhere to the principles of the Greenhouse Gas Protocol (GHG protocol) when reporting and setting targets on carbon emissions. The targets covering greenhouse gas emissions from our company’s operations (Scope 1 and 2) are consistent with reductions required to limit global warming to 1.5°C.

We recognise the need to broaden the scope of climate action to the supply chain and work with key suppliers to limit the carbon emission as the main priority under Scope 3. We share experience and learnings to support suppliers in finding the best carbon reducing measures, including energy efficiency and production or sourcing of renewable energy.

We reduce our CO₂ emissions by increasing the efficiency of our activities and implementing energy efficiency programmes. Secondly, we base our consumption on renewable energy, where we cooperate with energy suppliers. When we source renewable energy, we give priority to bringing additional renewable energy into the market.

Renewable energy can be based on wind, solar, hydro or biomass. When sourcing energy based on biomass, we ensure that the biomass comes from sustainable sources. Biomass, such as wood chips used for steam and heat production, must be based on sustainable sources certified by competent bodies. Biogas is based on our own yeast slurry and waste from farming and food industry.

Recognising the complexity and cross cutting nature of climate change, Novo Nordisk has taken a partnership approach to address this global challenge. We encourage partnerships and believe that this approach often leads to better and more innovative solutions.

Novo Nordisk is a member of RE100, EV100 and a campaign member of the Business Ambition for 1.5 °C. Novo Nordisk has an approved near-term target in line with 1.5 °C from the Science Based Targets Initiative (SBTi) and is committed to achieving net zero emissions by 2045, in line with the net zero requirements established by SBTi. Novo Nordisk is also a part of the World Economic Forum’s Alliance of CEO Climate Leaders.